HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin.

Abstract
Benomyl, a tubulin-targeted antimitotic antifungal agent, belongs to the benzimidazole group of compounds, which are known to inhibit the binding of colchicine to tubulin. Therefore, benomyl was thought to bind at or near the colchicine-binding site on tubulin. However, recent mutational studies in yeast and fluorescence studies involving competitive binding of benomyl and colchicine on goat brain tubulin suggested that benomyl may bind to tubulin at a site distinct from the colchicine-binding site. We set out to examine whether colchicine and benomyl bind to tubulin at distinct sites using a human cervical cancer (HeLa) cell line with the thinking that these agents should exert either additive or synergistic activity on cell proliferation if their binding sites on tubulin are different. We found that benomyl and colchicine synergistically inhibited the proliferation of HeLa cells and blocked their cell cycle progression at mitosis. The synergistic activity of benomyl and colchicine was also apparent from their strong depolymerizing effects on both the spindle and interphase microtubules when used in combinations, providing further evidence that these agents bind to tubulin at different sites. Using NMR spectroscopy, we finally demonstrated that benomyl and colchicine bind to tubulin at different sites and that the binding of colchicine seems to positively influence the binding of benomyl to tubulin and vice versa. Further, an analysis of the saturation transfer difference NMR data yielded an interesting insight into the colchicine-tubulin interaction. The data presented in this study provided a mechanistic understanding of the synergistic effects of benomyl and colchicine on HeLa cell proliferation.
AuthorsMarie-Jeanne Clément, Krishnan Rathinasamy, Elisabeth Adjadj, Flavio Toma, Patrick A Curmi, Dulal Panda
JournalBiochemistry (Biochemistry) Vol. 47 Issue 49 Pg. 13016-25 (Dec 09 2008) ISSN: 1520-4995 [Electronic] United States
PMID19049291 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzimidazoles
  • Carbamates
  • Tubulin
  • carbendazim
  • Colchicine
  • Benomyl
Topics
  • Benomyl (chemistry, pharmacology)
  • Benzimidazoles (chemistry, pharmacology)
  • Binding Sites
  • Carbamates (chemistry, pharmacology)
  • Cell Proliferation (drug effects)
  • Colchicine (chemistry, pharmacology)
  • Drug Synergism
  • HeLa Cells
  • Humans
  • Mitosis (drug effects)
  • Nuclear Magnetic Resonance, Biomolecular
  • Spindle Apparatus (drug effects)
  • Tubulin (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: